https://radars.digitellinc.com/p/cf/15th-annual-scientific-virtual-meeting-6
https://radars.digitellinc.com/p/s/postmarketing-surveillance-whats-the-next-move-22
https://radars.digitellinc.com/p/s/meeting-the-challenges-of-covid-19-in-postmarketing-surveillance-29
https://radars.digitellinc.com/p/s/defining-populations-of-interest-for-postmarketing-studies-37
https://radars.digitellinc.com/p/s/the-rest-of-the-story-other-drugs-misused-in-the-united-states-45
https://radars.digitellinc.com/p/s/break-51
https://radars.digitellinc.com/p/s/fdas-holistic-approach-to-addressing-polysubstance-use-and-the-drug-overdose-crisis-58
https://radars.digitellinc.com/p/s/panel-discussion-and-summary-64
https://radars.digitellinc.com/p/s/postmarketing-surveillance-whats-the-next-move-72
https://radars.digitellinc.com/p/cf/radars-r-system-16th-annual-scientific-virtual-meeting-evolving-safety-of-psychoactive-drugs-74
https://radars.digitellinc.com/p/s/evolving-safety-of-psychoactive-drugs-75
https://radars.digitellinc.com/p/s/heterogeneous-patterns-of-stimulant-initiation-a-study-of-typologies-76
https://radars.digitellinc.com/p/s/does-over-the-counter-mean-under-the-radar-77
https://radars.digitellinc.com/p/s/am-i-dreaming-the-misuse-and-abuse-of-psychedelic-medications-78
https://radars.digitellinc.com/p/s/answered-and-unanswered-questions-about-counterfeit-drugs-targeted-literature-review-80
https://radars.digitellinc.com/p/s/fake-drugs-real-risk-83
https://radars.digitellinc.com/p/s/a-mosaic-perspective-of-psychedelics-landscape-84
https://radars.digitellinc.com/p/s/psychedelics-in-the-real-world-using-real-world-evidence-to-prepare-for-approval-85
https://radars.digitellinc.com/p/s/evolving-safety-of-psychoactive-drugs-89
https://radars.digitellinc.com/p/cf/radars-r-system-17th-annual-scientific-virtual-meeting-93
https://radars.digitellinc.com/p/s/surveillance-of-psychoactive-drugs-opioids-psychedelics-and-cannabinoids-94
https://radars.digitellinc.com/p/s/application-of-systems-science-in-opioid-misuse-to-psychedelic-drugs-95
https://radars.digitellinc.com/p/s/policy-suggestions-to-support-the-safe-uses-of-psychedelics-96
https://radars.digitellinc.com/p/s/cannabis-lessons-learned-from-the-public-experience-in-colorado-97
https://radars.digitellinc.com/p/s/assessing-polysubstance-use-of-licit-gabapentin-xylazine-and-illicit-substances-98
https://radars.digitellinc.com/p/s/defining-polysubstance-use-in-a-national-population-based-survey-99
https://radars.digitellinc.com/p/s/satisfying-the-craving-for-novel-psychoactive-post-market-surveillance-100
https://radars.digitellinc.com/p/s/panel-discussion-and-summary-101
https://radars.digitellinc.com/p/s/surveillance-of-psychoactive-drugs-102
https://radars.digitellinc.com/p/s/break-103
https://radars.digitellinc.com/p/s/psychoactive-drugs-and-fixing-the-evidence-generation-system-a-fireside-chat-104